Skip to main content
OpenTrials

Clinical trial condition

Prostatic Diseases

Explore clinical trials studying Prostatic Diseases. Study availability and eligibility vary by location and protocol.

5,328 public trials 1,040 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Diseases trial results

Active, Not Recruiting

A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients

NCT05676203

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Ordensklinikum Linz GmbH, Elisabethinen Linz, Austria
  • Krankenhaus der Barmherzigen Brüder Vienna, Austria
  • Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • Klinikum Wetzlar Wetzlar, Hesse, Germany
View all 43 locations
View Trial Details
Active, Not Recruiting

Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.

NCT04962919

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • CPO Pucrs Porto Alegre, Rio Grande do Sul, Brazil
  • Centro de Estudos e Pesquisas de Hematologia e Oncologia - CEPHO Santo André, São Paulo, Brazil
  • Sírio Libanês São Paulo, Brazil
  • Centro Paulista de Oncologia São Paulo, Brazil
View Trial Details
Active, Not Recruiting

Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms

NCT03763253

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Wirral University Teaching Hospital, Wirral University Teaching Hospital NHS Foundation Trust Birkenhead, United Kingdom
  • Glan Clwyd Hospital Bodelwyddan, United Kingdom
  • Darent Valley Hospital Dartford, United Kingdom
  • Royal Devon and Exeter NHS Trust Exeter, United Kingdom
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

NCT05032040

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +34 more
Locations
  • Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 17 locations
View Trial Details

Related conditions